Achieve Life Sciences Inc (SP4P) — Financial Flexibility Index
Achieve Life Sciences Inc (SP4P) has a Financial Flexibility Index of -0.89x as of December 2025. Free cash flow of €-17.98 Million (operating CF €-17.98 Million minus capex €0.00) represents -1% of total liabilities (€20.27 Million). Check Achieve Life Sciences Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Achieve Life Sciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Achieve Life Sciences Inc across 10 annual periods. See working capital to net assets of Achieve Life Sciences Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Achieve Life Sciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Achieve Life Sciences Inc. For the full company profile including market capitalisation, see SP4P stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | €-49.46 Million | €-49.47 Million | €20.27 Million | ▼ -45.3% |
| 2024 | -1.68x | €-29.77 Million | €-29.77 Million | €17.73 Million | ▼ -42.9% |
| 2023 | -1.17x | €-24.46 Million | €-24.48 Million | €20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | €-37.55 Million | €-37.55 Million | €21.67 Million | ▼ -14.6% |
| 2021 | -1.51x | €-29.44 Million | €-29.44 Million | €19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | €-13.46 Million | €-13.47 Million | €3.01 Million | ▲ +10.8% |
| 2019 | -5.01x | €-15.16 Million | €-15.22 Million | €3.03 Million | ▼ -55.4% |
| 2018 | -3.22x | €-10.58 Million | €-10.62 Million | €3.28 Million | ▲ +28.4% |
| 2017 | -4.50x | €-9.06 Million | €-9.11 Million | €2.01 Million | ▼ -24437.5% |
| 2016 | -0.02x | €-156.00K | €-202.00K | €8.50 Million | — |